SS Innovations International, Inc. (Nasdaq: SSII) announced that its SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines, expanding the reach of remote surgical capabilities. The company also reported that more than 150 cumulative telesurgeries have been successfully performed using the system, primarily in India, demonstrating growing adoption of the technology.
The approval follows a series of high-volume telesurgery events showcasing the system's capabilities. On February 14, 2026, 18 inter-hospital telesurgeries were performed over eight hours between Indore and Bhopal, India, including 13 gastric bypass procedures by Dr. Mohit Bhandari and 5 complex gynecological surgeries by Dr. Priya Bhave Chittawar. These procedures utilized the SSi MantrAsana Tele Surgeon Console, a portable chair-based version of the surgeon command center designed for telesurgeries from diverse settings.
This milestone builds on a previous telesurgery marathon on December 23, 2025, where nine surgeons completed 24 telesurgeries within 12 hours using the SSi Mantra at SS Innovations' headquarters, covering ten different procedure types including cardiac surgeries. Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, stated, "The SSi Mantra continues to pioneer telesurgery, not merely in concept but in real-world practice. We are thrilled to receive approval in Indonesia and the Philippines and to surpass 150 telesurgeries, indicating significant traction in enabling remote surgical care."
The company is hosting the Global Multi-Specialty Robotic Surgery Conference 2026 (SMRSC 2026) in New Delhi, India from April 9-11, where more than 20 live telesurgeries will be performed using the SSi Mantra. Registration is available at https://ssinnovations.com/SMRSC_2026/register/.
SS Innovations develops the SSi Mantra, a modular multi-arm system with features including 3 to 5 robotic arms, an open-faced surgeon console, 3D 4K visualization, and over 40 robotic instruments for various specialties. The system has been clinically validated in India for more than 100 procedure types. The company aims to make robotic surgery affordable and accessible globally, with plans to expand its presence. More information is available at ssinnovations.com.
